Status:

COMPLETED

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD

Lead Sponsor:

Allergan

Conditions:

Macular Degeneration

Eligibility:

All Genders

50+ years

Phase:

PHASE1

Brief Summary

This study will evaluate the safety and to characterize the systemic pharmacokinetics of free and vascular endothelial growth factor (VEGF)-bound abicipar following multiple monthly intravitreal injec...

Eligibility Criteria

Inclusion

  • Japanese male or female patients
  • Presence of active subfoveal and/or juxtafoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD)

Exclusion

  • History of or active periocular, ocular, or intraocular infection
  • Previous use of ocular anti-angiogenic therapy within 1 month (ranibizumab), 6 weeks (pegaptanib), or 2 months (bevacizumab and aflibercept) of Day 1 for the treatment of neovascular AMD or neovascular eye diseases other than AMD
  • Macular hemorrhage that involves the center of fovea in the study eye
  • Previous use of verteporfin photodynamic therapy (PDT) or previous therapeutic radiation in the region
  • Treatment with ocular corticosteroid injections or implants within 6 months in the study eye
  • History or evidence of eye surgery: Pars plana vitrectomy, Submacular surgery or other surgical interventions for AMD, Incisional glaucoma surgery or Cataract or refractive surgery within the last 3 months
  • AMD or neovascular eye diseases other than AMD in the non-study eye that require anti-VEGF treatment

Key Trial Info

Start Date :

November 28 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 8 2018

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT03335852

Start Date

November 28 2017

End Date

October 8 2018

Last Update

November 1 2018

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Kimura Eye and Internal Medicine Hospital

Kure, Hiroshima, Japan, 737-0029

2

Musashi Dream Clinic

Tennouji-ku, Osaka, Japan, 543-0027

3

Takeuchi Eye Clinic

Taito-ku, Tokyo, Japan, 111-0051

4

Souseikai Hakata Clinic

Fukuoka, Japan, 812-0025